For purchasing or obtaining a quotation, please visit the Distributor page
to find your local distributor.
to find your local distributor.
HOME > Product search results
Searched by
MHC Allele - A*11:01
Product
[-] MHC tetramer（62）
>Class I（62）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
MHC tetramer（62）
1
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M111-1 |
HLA-A*11:01 EBV LMP2 Tetramer-SSCSSCPLSK-PE |
|
|||
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSCSSCPLSK | 340-349 | ４°C | ||||
|
|
TS-M135-2 |
HLA-A*11:01 EBV LMP2 S9T Tetramer-SSCSSCPLTK-APC |
|
|||
|
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSCSSCPLTK | 340-349 | ４°C | ||||
|
|
TS-M111-2 |
HLA-A*11:01 EBV LMP2 Tetramer-SSCSSCPLSK-APC |
|
|||
|
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSCSSCPLSK | 340-349 | ４°C | ||||
|
|
TS-M135-1 |
HLA-A*11:01 EBV LMP2 S9T Tetramer-SSCSSCPLTK-PE |
|
|||
|
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSCSSCPLTK | 340-349 | ４°C | ||||
|
|
TS-M028-1 |
T-Select HLA-A*11:01 EBV EBNA3B 399-408 Tetramer-AVFDRKSDAK-PE |
|
|||
|
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| AVFDRKSDAK | 399-408 | ４°C | ||||
|
|
TS-M029-1 |
T-Select HLA-A*11:01 EBV EBNA3B 416-424 Tetramer-IVTDFSVIK-PE |
|
|||
|
|
virus | PE | A*11:01 | 50 tests | 1-9 | |
| IVTDFSVIK | 416-424 | ４°C | ||||
|
|
TS-M012-1 |
T-Select HLA-A*11:01 CMV pp65 Tetramer-ATVQGQNLK-PE |
|
|||
|
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATVQGQNLK | 501-509 | ４°C | ||||
|
|
TS-M152-2 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-APC |
|
|||
|
|
negative | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATAAAAAAK | ４°C | |||||
|
|
TS-M152-3 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-FITC |
|
|||
|
|
negative | FITC | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATAAAAAAK | ４°C | |||||
|
|
TS-M023-1 |
T-Select HLA-A*11:01 HTLV-1 Tax88-96 Tetramer-KVLTPPITH-PE |
|
|||
|
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| KVLTPPITH | 88-96 | ４°C | ||||
|
|
TS-M152-1 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-PE |
|
|||
|
|
negative | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATAAAAAAK | ４°C | |||||
|
|
TS-M024-1 |
T-Select HLA-A*11:01 HTLV-1 Tax272-280 Tetramer-QSSSFIFHK-PE |
|
|||
|
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| QSSSFIFHK | 272-280 | ４°C | ||||
|
|
TS-7304-1R |
QuickSwitch™ Quant HLA-A*11:01 Tetramer Kit-PE (2-8℃) |
|
|||
|
|
Others | PE | A*11:01 | 1 kit | 10 or more | |
| - | ４°C | |||||
|
|
TS-7304-2R |
QuickSwitch™ Quant HLA-A*11:01 Tetramer Kit-APC (2-8℃) |
|
|||
|
|
Others | APC | A*11:01 | 1 kit | 1-9 | |
| - | ４°C | |||||
|
|
TS-7304-2F |
QuickSwitch™ Quant HLA-A*11:01 Tetramer Kit-APC (frozen) |
|
|||
| Others | APC | A*11:01 | 1 kit | 1-9 | ||
| Custom | －２０°C | |||||
|
|
TS-7304-1F |
QuickSwitch™ Quant HLA-A*11:01 Tetramer Kit-PE (frozen) |
|
|||
| Others | PE | A*11:01 | 1 kit | 10 or more | ||
| Custom | －２０°C | |||||
|
|
TS-7304-4F |
QuickSwitch™ Quant HLA-A*11:01 Tetramer Kit-BV421 (frozen) |
|
|||
| Others | BV421 | A*11:01 | 1 kit |
0 (Contact us) |
||
| Custom | －２０°C | |||||
|
|
TS-7304-4R |
QuickSwitch™ Quant HLA-A*11:01 Tetramer Kit-BV421 (2-8℃) |
|
|||
|
|
Others | BV421 | A*11:01 | 1 kit |
0 (Contact us) |
|
| - | ４°C | |||||
|
|
TC-8016-1 |
HLA-A*11:01 EGFR852-860 L858R Tetramer-KITDFGRAK-PE
|
|
|||
|
|
Others | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| KITDFGRAK | 852-860 | ４°C | ||||
|
|
TC-8025-1 |
HLA-A*11:01 HPV16 E789-97 Tetramer-IVCPICSQK-PE
|
|
|||
|
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| IVCPICSQK | 89-97 | ４°C | ||||
|
|
TC-8001-1 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | ４°C | ||||
|
|
TC-8023-2 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | ４°C | ||||
|
|
TC-8022-1 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TS-M257-1 |
HLA-A*11:01 HBcAg Tetramer-STLPETTVVRR-PE
|
|
|||
|
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| STLPETTVVRR | 141-151 | ４°C | ||||
|
|
TC-8002-2 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | ４°C | ||||
|
|
TS-M256-1 |
HLA-A*11:01 Dengue virus NS3 Tetramer-GTSGSPIIDK-PE
|
|
|||
|
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| GTSGSPIIDK | 133-142 | ４°C | ||||
|
|
TC-8012-2 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | ４°C | ||||
|
|
TC-8005-2 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | ||||
|
|
TS-M264-2 |
HLA-A*11:01 EBV BRLF1 Tetramer-ATIGTAMYK-APC
|
|
|||
|
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATIGTAMYK | 134-142 | ４°C | ||||
|
|
TC-8021-2 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | ４°C | ||||
|
|
TC-8016-2 |
HLA-A*11:01 EGFR852-860 L858R Tetramer-KITDFGRAK-APC
|
|
|||
|
|
Others | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| KITDFGRAK | 852-860 | ４°C | ||||
|
|
TC-8004-2 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | ４°C | ||||
|
|
TS-M264-1 |
HLA-A*11:01 EBV BRLF1 Tetramer-ATIGTAMYK-PE
|
|
|||
|
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATIGTAMYK | 134-142 | ４°C | ||||
|
|
TS-M263-1 |
HLA-A*11:01 Perilipin-2 Tetramer-TSALPIIQK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| TSALPIIQK | 63-71 | ４°C | ||||
|
|
TS-M259-1 |
HLA-A*11:01 HERC1 Neoepitope Tetramer-ASNASSAAK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| ASNASSAAK | ４°C | |||||
|
|
TC-8023-1 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | ４°C | ||||
|
|
TC-8021-1 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | ４°C | ||||
|
|
TC-8014-1 |
HLA-A*11:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | ４°C | ||||
|
|
TS-M257-2 |
HLA-A*11:01 HBcAg Tetramer-STLPETTVVRR-APC
|
|
|||
|
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| STLPETTVVRR | 141-151 | ４°C | ||||
|
|
TS-M261-1 |
HLA-A*11:01 MATN2 Neoepitope Tetramer-KTLTSVFQK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| KTLTSVFQK | ４°C | |||||
|
|
TC-8015-2 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | ４°C | ||||
|
|
TC-8004-1 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | ４°C | ||||
|
|
TC-8003-1 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | ||||
|
|
TC-8001-2 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | ４°C | ||||
|
|
TS-M263-2 |
HLA-A*11:01 Perilipin-2 Tetramer-TSALPIIQK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| TSALPIIQK | 63-71 | ４°C | ||||
|
|
TC-8015-1 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | ４°C | ||||
|
|
TC-8012-1 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | ４°C | ||||
|
|
TC-8005-1 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | ||||
|
|
TS-M262-2 |
HLA-A*11:01 KIF26B Neoepitope Tetramer-SSYTGFANK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSYTGFANK | ４°C | |||||
|
|
TS-M256-2 |
HLA-A*11:01 Dengue virus NS3 Tetramer-GTSGSPIIDK-APC
|
|
|||
|
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| GTSGSPIIDK | 133-142 | ４°C | ||||
|
|
TS-M262-1 |
HLA-A*11:01 KIF26B Neoepitope Tetramer-SSYTGFANK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSYTGFANK | ４°C | |||||
|
|
TS-M260-1 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| CILGKLFTK | ４°C | |||||
|
|
TC-8025-2 |
HLA-A*11:01 HPV16 E789-97 Tetramer-IVCPICSQK-APC
|
|
|||
|
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| IVCPICSQK | 89-97 | ４°C | ||||
|
|
TC-8022-2 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TC-8003-2 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | ||||
|
|
TC-8002-1 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | ４°C | ||||
|
|
TS-M261-2 |
HLA-A*11:01 MATN2 Neoepitope Tetramer-KTLTSVFQK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| KTLTSVFQK | ４°C | |||||
|
|
TS-M258-1 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-PE
|
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAAGVGK | ４°C | |||||
|
|
TC-8014-2 |
HLA-A*11:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | ４°C | ||||
|
|
TS-M259-2 |
HLA-A*11:01 HERC1 Neoepitope Tetramer-ASNASSAAK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| ASNASSAAK | ４°C | |||||
|
|
TS-M260-2 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| CILGKLFTK | ４°C | |||||
|
|
TS-M258-2 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-APC
|
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAAGVGK | ４°C | |||||
1
- The availability is based on the information in Japan at 00:05, Feb 7, 2026 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.